We Reach Specialists with Preferred Highlights from the EHA

The EHA Congress was filled with important new data within CLL, AML, lymphomas, and myeloma. These data guide both current and future treatment options for hematological patients. Once again, in valuable collaboration with international, Nordic, and Danish specialists, we have put the new data into perspective. Scroll through the EHA congress site and get an overview. We are looking forward to attend the ASH congress in December, where we have already received reports of exciting news that will make a significant difference in the clinic and for patients. Book a meeting if you would like to hear more about the opportunities we offer if you have important new data to get across to clinicians at ASH